![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjAvMTEvMTIvbWVkaWNhbG1hcmlqdWFuYWlucnhib3R0bGUtYWRvYmVzdG9jay1jcmVkaXQtYXRvbWF6dWwtcmVzaXplZC5qcGc.LQuEqRfwW94.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Atomazul | Adobe Stock
The Pennsylvania Medical Marijuana Advisory Board held a quarterly meeting Nov. 10, where it rejected adding insomnia to the state’s list of qualifying conditions, according to a TribLive.com report.
The board voted 7-4 to reject insomnia as a new qualifying condition, and tabled a discussion on whether to add traumatic brain injuries to the list, the news outlet reported.
There are more than 460,000 Pennsylvanians currently enrolled in the state’s medical cannabis program, according to TribLive.com, and while there are currently 23 qualifying conditions, the vast majority of patients qualify under anxiety disorders, chronic pain and post-traumatic stress disorder (PTSD).
The public can apply for new conditions to be added to the list, and the Medical Marijuana Advisory Board considers the applications and makes recommendations, although Pennsylvania Health Secretary Rachel Levine makes the final decision on which conditions make the list, TribLive.com reported.
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial